WHO ICTRP trial
A Study to Evaluate the Safety and Tolerability of Long-term Administration of…
JPRN-jRCT2061200043 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-jRCT2061200043 |
|---|---|
| Public title | A Study to Evaluate the Safety and Tolerability of Long-term Administration of Gantenerumab in Participants With Alzheimer's Disease (AD) |
| Scientific title | An Open-Label, Multicenter, Rollover Study to Evaluate the Safety and Tolerability of Long-Term Administration of Gantenerumab in Participants With Alzheimer's Disease |
| Primary sponsor | Szofia S Bullain, M.D. |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 3 |
| Countries | AUSTRALIA;Japan;CANADA;Japan;CHILE;Japan;ITALY;Japan;MEXICO;Japan;NETHERLANDS;Japan;POLAND;Japan;RUSSIAN FEDERATION;Japan;KOREA;Japan;SPAIN;Japan;SWITZERLAND;Japan;TURKEY;Japan;UNITED… |
| Conditions | Alzheimer's disease |
| Interventions | Gantenerumab will be administered as SC injection Q4W |
| Registration date | Aug 1, 2021 |
| Target size | 116 |
| Secondary IDs | NCT04339413 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: